Hansa Biopharma Falls After Carnegie Chops 26% Off Their Price Target

• (PLX AI) - Hansa Biopharma fell 5% in morning trading after Carnegie analysts cut their price target on the stock to SEK 140 from SEK 190.
• • Recommendation remains hold
• • Hansa Biopharma may be seeking to raise additional capital already next year, Carnegie said
• • Meanwhile, catalysts to accelerate the slow commercial trajectory in the EU remain distant, with no additional data likely in the next 12 months, the analysts said